# Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM

> **NCT04532021** · — · UNKNOWN · sponsor: **Cengiz Gokcek Women's and Children's Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Preterm Premature Rupture of Membranes

## Interventions

- **DIAGNOSTIC_TEST:** matrix metalloproteinase 14, neopterin, and orosomucoid 1 measurements

## Key facts

- **NCT ID:** NCT04532021
- **Lead sponsor:** Cengiz Gokcek Women's and Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-25
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04532021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04532021, "Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04532021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*